General Information of Drug (ID: DMZS5RN)

Drug Name
PP-007 Drug Info
Indication
Disease Entry ICD 11 Status REF
Ischemic stroke 8B11.5Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMZS5RN

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
LMT-X DMOFIBM Acute myeloid leukaemia 2A60 Phase 3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TAR DNA binding protein 43 (TARDBP) TT9RZ03 TADBP_HUMAN Not Available [1]

References

1 ClinicalTrials.gov (NCT04677777) A Randomized, Phase 1, Contemporaneously Controlled, Multicenter Study to Assess the Safety of PP-007 in Subjects With Acute Ischemic Stroke. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)